- Home
- OGI vs CVRX Comparison
OGI vs CVRX Comparison
Compare OGI & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OGI | CVRX |
|---|---|---|
| Founded | 2013 | 2000 |
| Country | Canada | United States |
| Employees | 1137 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.0M | 160.8M |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | OGI | CVRX |
|---|---|---|
| Price | $1.07 | $5.03 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $10.50 |
| AVG Volume (30 Days) | ★ 528.2K | 340.7K |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.02 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $56,651,000.00 |
| Revenue This Year | $20.10 | $17.17 |
| Revenue Next Year | $13.92 | $17.69 |
| P/E Ratio | $13.91 | ★ N/A |
| Revenue Growth | N/A | ★ 10.45 |
| 52 Week Low | $1.04 | $4.37 |
| 52 Week High | $2.24 | $11.30 |
Technical Indicators
Market Signals| Indicator | OGI | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 36.90 | 33.45 |
| Support Level | N/A | $4.37 |
| Resistance Level | $1.21 | $5.95 |
| Average True Range (ATR) | 0.05 | 0.38 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 12.12 | 11.64 |
Price Performance
Historical ComparisonAbout OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.